Analyze Your Search


  • Action links for each search result record
    • Bookmark: Allows you to Bookmark the page for easy future retrieval 
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • More Info: Shows full summary of content record
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Follow" button to the right of the search box. 
  Follow Topic   Edit Search

Stroke is a medical emergency that requires rapid diagnosis and treatment. The hallmark of a stroke is the abrupt interruption of cerebral blood flow to a specific brain region, resulting in neurologic deficits. Fluctuation of functional defecits after stroke onset or a brief deficit known as transient ischemic attack (TIA) suggests tissue at risk for infarction that may be rescued by reestablishing perfusion. The time of onset is critical if thrombolytic therapy is to be administered. Onset is typically sudden. Common clinical presentations are sudden onset of severe headache, lethargy or coma, fever, vomiting, seizures, and low back. From the Washington Manual of Medical Therapeutics, 35e

Your search returned 43 results
from the time period: last 30 days.
Sort by Relevance / Date Group By Journal / No Grouping
Journal of the American Heart Association 
AbstractText: The effects of white matter hyperintensity volume and subclinical brain infarcts on the risk of incident stroke, its ischemic subtypes, and mortality require further study in diverse samples AbstractText: Stroke-free participants in the Northern Manhattan Study underwent magnetic resonance ... Those with subclinical brain infarct had greater risk for all stroke types (HR: 1.9; 95% CI, 1.1-3.3), ischemic stroke (HR: 2.2; 95% CI, 1.3-3.8), lacunar (HR: 4.0; 95% CI, 1.3-12.3), and cryptogenic stroke (HR: 3.6; 95% CI, 1.0-12.7), without significant heterogeneity across ...
Cardiovascular Diseases (16)
Stroke (17), Leukoencephalopathies (1), more mentions
Journal of neurosurgery 
Keyword: MCA = middle cerebral artery. Keyword: PHASES = population, hypertension, age, size of aneurysm, earlier SAH from another aneurysm, and site of aneurysm. Keyword: SAH = subarachnoid hemorrhage. Keyword: UIA = unruptured intracranial aneurysm. Keyword: WFNS = World Federation of Neurosurgical Societies. Keyword: anatomical analysis. Keyword: middle cerebral artery bifurcation aneurysms. Keyword: predictive factors.
Cardiovascular Diseases (1)
Aneurysm (21), Subarachnoid Hemorrhage (4), Cerebral Hemorrhage (1), more mentions
Journal of the American College of Cardiology 
... for the occurrence of MACCE, which included a composite of stroke or transient ischemic attack (TIA), myocardial infarction, acute decompensated HF, or cardiovascular death ... remain significantly associated with advanced LGE following DRS stratification was stroke or TIA (hazard ratio: 3.94; 95% confidence interval: 1.72 to ... with increased MACCE risk, driven primarily by increased risk of stroke or TIA Keyword: MACCE.
Cardiovascular Diseases (8)
Fibrosis (5), Transient Ischemic Attack (4), Myocardial Infarction (2), more mentions
Journal of the American Heart Association 
AbstractText: Previous meta-analyses on meat intake and risk of stroke did not report the effect of white meat (poultry meat, excluding fish) and did not examine stroke incidence and mortality separately ... and processed meats to white meat for the prevention of stroke may be considered in clinical practice Keyword: cerebrovascular accident. Keyword: cerebrovascular infarction.
Stroke (12), Ischemia (1), more mentions
Journal of neurosurgery 
... as repositioning of the clips may lead to resolution of visual deterioration Keyword: ACoA = anterior communicating artery. Keyword: APD = afferent pupillary defect. Keyword: CON = compressive optic neuropathy. Keyword: SAH = subarachnoid hemorrhage. Keyword: WFNS = World Federation of Neurosurgical Societies. Keyword: afferent pupillary defect. Keyword: anterior communicating artery aneurysm. Keyword: intracranial aneurysm. Keyword: optic nerve injuries. Keyword: surgical clips. Keyword: vascular disorders.
Aneurysm (4), Afferent Pupillary Defect (3), Anterior Communicating Artery Aneurysm (2), more mentions
Journal of neurosurgery 
Abstract: OBJECTIVE Compressive cranial nerve syndromes can be useful bedside clues to the diagnosis of an enlarging intracranial aneurysm and can also guide subsequent evaluation, as with an acute oculomotor nerve (cranial nerve [CN] III) palsy that is presumed to be a posterior communicating artery aneurysm and a surgical emergency ...
Aneurysm (17), Pica (12), Paralysis (12), more mentions
... common in the aging population and implicated in many ischemic strokes... 3.0 (heart failure, 1.4%; hypertension, 54%; diabetes mellitus, 30%; prior stroke/transient ischemic attack, 6.5%; arterial disease, 15.9%; all CHADS-VASc risk factors were ... There was a similar number of stroke/transient ischemic attack/systemic embolic events (6 versus 10, iECG versus RC; hazard ...
Cardiovascular Diseases (9), Endocrine Disorders (1)
Atrial Fibrillation (3), Transient Ischemic Attack (2), Stroke (1), more mentions
Journal of cardiovascular electrophysiology 
AbstractText: Stroke risk is a significant concern in patients with atrial fibrillation ... Low stroke risk patients (CHADS2 VASc 0-2) are often treated long ... We compared 1- and 3-year outcomes for cerebrovascular accident (CVA), transient ischemic attack (TIA), gastrointestinal (GI) bleeding, genitourinary (GU) bleeding, any bleeding, and ... Keyword: warfarin, stroke, stroke risk.
Cardiovascular Diseases (9), Endocrine Disorders (1)
Stroke (4), Transient Ischemic Attack (4), Atrial Fibrillation (3), more mentions
AbstractText: To assess whether smoking cessation after an ischemic stroke or TIA improves outcomes compared to continued smoking AbstractText: We ... men and women enrolled in the Insulin Resistance Intervention After Stroke (IRIS) trial who were randomized to pioglitazone or placebo within 180 days of a qualifying stroke or TIA and followed up for a median of 4.8 ...
Cardiovascular Diseases (11), Smoking Cessation (3), Endocrine Disorders (1)
Myocardial Infarction (1), Coronary Artery Disease (1), Hypertension (1), more mentions
Journal of the American College of Cardiology 
Median hospital stay was 3.0 days, and the overall major adverse event rate was 7.3. Median long-term follow-up was 3.1 years, and overall major adverse cardiac event rate was 19.9% (death rate: 1.2%; recurrent MI: 16.8%; stroke/transient ischemic attack: 1.2%; revascularization: 5.8. Recurrent SCAD occurred in 10.4% of patients.
Cardiovascular Diseases (4)
Hypertension (3), Myocardial Infarction (3), Fibromuscular Dysplasia (2), more mentions
Journal of the American College of Cardiology 
... confidence intervals (CIs) of the following outcomes: acute cardiac event; stroke; venous thromboembolism; hypertension; and diabetes mellitus, comparing women who received ... There was a trend toward higher risk of stroke (pooled HR: 1.25; 95% CI: 0.96 to 1.63; I(2 ... about the longer term cardiovascular safety of these treatments, particularly stroke.
Cardiovascular Diseases (9), Endocrine Disorders (2)
Hypertension (2), Diabetes Mellitus (2), Venous Thromboembolism (2), more mentions
Lancet (London, England) 
The primary endpoint was net clinical benefit (cardiovascular death, myocardial infarction, stroke or bleeding grade 2 or higher according to Bleeding Academic Research Consortium [BARC ... was no increase in the combined risk of cardiovascular death, myocardial infarction, or stroke in the de-escalation group (32 patients [3%]) versus in the control group ...
Cardiovascular Diseases (6)
Acute Coronary Syndrome (4), Myocardial Infarction (2), more mentions
The New England journal of medicine 
... compared liraglutide, a glucagon-like peptide 1 analogue, with placebo in patients with type 2 diabetes and high cardiovascular risk who were receiving usual care, we found that liraglutide resulted in lower risks of the primary end point (nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes) and death.
Endocrine Disorders (4), Kidney Disease (3), Cardiovascular Diseases (1)
Diabetes Mellitus, Type 2 (4), Acute Kidney Injury (2), Diabetic Nephropathies (2), more mentions
The New England journal of medicine 
The trial also tested for the noninferiority of dual therapy with dabigatran (both doses combined) to triple therapy with warfarin with respect to the incidence of a composite efficacy end point of thromboembolic events (myocardial infarction, stroke, or systemic embolism), death, or unplanned revascularization. Results The incidence of the primary end point was 15.4% in the 110-mg dual-therapy ...
Cardiovascular Diseases (5)
Atrial Fibrillation (4), Myocardial Infarction (1), Embolism (1), more mentions
Annals of internal medicine 
... the first qualifying lipid panel served as the study baseline AbstractText: Time from baseline to the first occurrence of a major ASCVD event (myocardial infarction, stroke, or cardiovascular death) within 5 years, modeled as a function of a locally derived neighborhood disadvantage index (NDI) and the predicted 5-year ASCVD event ...
Cardiovascular Diseases (3)
Cardiovascular Diseases (2), Myocardial Infarction (1), more mentions
The New England journal of medicine 
... atherosclerotic vascular disease to receive rivaroxaban (2.5 mg twice daily) plus aspirin (100 mg once daily), rivaroxaban (5 mg twice daily), or aspirin (100 mg once daily. The primary outcome was a composite of cardiovascular death, stroke, or myocardial infarction. The study was stopped for superiority of the rivaroxaban-plus-aspirin group after a mean follow-up of 23 months.
Cardiovascular Diseases (1)
Vascular Diseases (2), Myocardial Infarction (1), Cardiovascular Diseases (1), more mentions
The New England journal of medicine 
The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. Results At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points ...
Muscular and Skeletal Diseases (2), Cardiovascular Diseases (2)
Myocardial Infarction (2), Cardiovascular Diseases (1), Unstable Angina (1), more mentions
... therapy (IT) on functional impairment, defined by a primary outcome of death or symptomatic stroke causing modified Rankin Scale (mRS) score ≥2... but was more frequent with increasing grades for IT (p < 0.001) AbstractText: Death or stroke with functional impairment in ARUBA after a median follow-up of 33 months was ...
Cardiovascular Diseases (2)
Arteriovenous Malformations (2), Stroke (2), more mentions
Journal of the American College of Cardiology 
The rates of cardiovascular (CV) death, MI, and stroke as well as TIMI major bleeding were analyzed at yearly ... The risk of CV death, MI, or stroke in the placebo arm remained roughly constant over the trial ... MI remain at persistent high risk for CVD, MI, and stroke as late as 5 years after MI.
Cardiovascular Diseases (4)
Myocardial Infarction (3), more mentions
The purpose of this American Heart Association (AHA)/American Stroke Association presidential advisory is to provide an initial definition of ... we recommend following previously published guidance from the AHA/American Stroke Association, Institute of Medicine, and Alzheimer's Association that incorporates control ... 20% and to reduce deaths resulting from cardiovascular disease and stroke by 20% by the year 2020.
Neuroscience (3), Neurological and Central Nervous System Diseases (1), Cardiovascular Diseases (1)
Stroke (6), Dementia (2), Cardiovascular Diseases (1), more mentions
1 2 3  | Next Page»